NDC 48433-048-01 - Hydralazine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 48433-048
- Requested NDC
- 48433-048-01
- Package NDCs from labels
- 48433-048-01, 48433-048-20
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-09-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydralazine Hydrochloride - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-09-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Hydralazine Hydrochloride - Safecor Health, LLC | Safecor Health, LLC | 2026-03-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 48433-048-01 | Hydralazine Hydrochloride | 1 in 1 BLISTER PACK | TABLET | 1 | 2 | |
| 48433-048-20 | Hydralazine Hydrochloride | 100 in 1 CARTON | TABLET | 100 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 4ELV7Z65AP |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | A-S Medication Solutions | e617023e-b060-4db9-a97e-e2b11a37901e | 2023-08-28 | Warnings, Adverse reactions | ANDA088468 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | 62475f78-5410-43c2-a11d-54a8363c3ae1 | 2023-07-25 | Warnings, Adverse reactions | 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 7979c865-737d-d999-e053-2a91aa0abc5e | 2023-05-16 | Warnings, Adverse reactions | FD171B778Y |
| HydrALAZINE hydrochloride | HYDRALAZINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | d89d981d-64cf-7321-e053-2995a90aab4a | 2023-05-03 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | dd2cd8a1-7bdd-05e4-e053-2995a90ad366 | 2023-05-02 | Warnings, Adverse reactions | FD171B778Y |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | Cadila Pharmaceuticals Limited | 3a7562a8-2f67-4411-ac4a-ab7924193e82 | 2022-12-29 | Warnings, Adverse reactions | 905225 905395 905222 FD171B778Y |
| hydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | c3797028-c625-4f70-ae69-8a5f6f23f1b8 | 2022-08-09 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 8223c44a-73a9-4da5-a468-d1d8bdb0bbd6 | 2022-05-18 | Warnings, Adverse reactions | FD171B778Y |
| isosorbide dinitrate and hydralazine hydrochloride | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | Wilshire Pharmaceuticals | 620a0680-aad0-4923-84be-7393c0cbdcbd | 2022-04-14 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Radha Pharmaceuticals, Inc. | 149fa857-30ad-451d-b6e2-0000483ccc97 | 2021-03-12 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | ScieGen Pharmaceuticals, Inc. | 500b7f76-5f4e-4e7d-85c3-18b9f66d7504 | 2021-03-04 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Exelan Pharmaceuticals Inc. | 811831f9-a844-463a-874d-fb8407659f0b | 2020-09-04 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | 63f388e0-9f3d-4902-990c-9a105aa098ad | 2020-09-01 | Warnings, Adverse reactions | 905225 FD171B778Y |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | dfd60a79-2a30-41e6-b000-a144730099a8 | 2019-10-01 | Warnings, Adverse reactions | 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | 48cf71dd-19dc-4239-9117-ebcf9731a45d | 2019-10-01 | Warnings, Adverse reactions | 905199 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | American Regent, Inc. | 17210abc-58f6-442e-8ff2-7971333c82f6 | 2019-05-06 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Ascend Laboratories, LLC | e7bfec3d-5222-4a26-8f99-6c2a28e14aa6 | 2017-12-28 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | bfbd5960-ae6b-46f5-adfa-e330d7a21dfa | 2017-12-21 | Warnings, Adverse reactions | ANDA088467 905225 FD171B778Y |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 921c8693-84c2-4313-a2a6-ab3be637d554 | 2016-07-14 | Warnings, Adverse reactions | 905222 FD171B778Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.